Advancing COPD Care
Brian Bizik, MS, PA-C, DFAAPA
Physician associate (PA) Brian Bizik takes viewers through a four-part video series exploring the evolving understanding of type 2 inflammation in chronic obstructive pulmonary disease (COPD).
Each video covers essential topics—from the pathophysiology of eosinophilic COPD and diagnostic biomarkers such as blood eosinophil count to targeted therapies and strategies for preventing life-altering exacerbations. With clear, practical insights grounded in current guidelines, the series equips clinicians across care settings to identify and manage inflammatory phenotypes of COPD more effectively. The goal: personalized, precision-based care that improves patient outcomes and quality of life.
Video 1: Inside COPD: The Inflammation Behind the Disease
This video explores the inflammatory mechanisms behind COPD, with a focus on type 2 inflammation. It highlights how immune dysfunction contributes to symptoms, progression, and treatment decisions.
Video 2: Unpacking COPD: Patient Assessment for Targeted Care
This video covers how to accurately diagnose and characterize COPD, including the use of spirometry and blood eosinophil counts. It emphasizes recognizing non-smoking-related causes and identifying treatable traits.
Video 3: The Right Treatment for the Right Patient: Personalizing COPD Therapy
This video outlines how to tailor COPD treatment based on symptoms, exacerbation risk, and COPD type. It reviews GOLD 2025 therapy guidelines and strategies for therapy escalation.
Video 4: At High Risk: Understanding COPD Exacerbations and Type 2 Inflammation
This video focuses on COPD exacerbations, their risks, and how type 2 inflammation increases the likelihood of frequent or severe episodes. It emphasizes early intervention and options like biologics for high-risk patients.
Supported by
